HF
CGEM icon

HRT Financial’s Cullinan Oncology CGEM Stock Holding History

HRT Financial’s Portfolio CGEM Stock Details CGEM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$548K Sell
38,586
-45,481
-54% -$584K ﹤0.01% 2447
2025
Q4 		$870K Buy
84,067
+41,958
+100% +$378K ﹤0.01% 1804
2025
Q3 		$249K Buy
+42,109
New +$308K ﹤0.01% 2292
2025
Q2 		– Sell
-20,850
Closed -$157K – 2729
2025
Q1 		$157K Buy
+20,850
New +$200K ﹤0.01% 2074
2023
Q3 		– Sell
-28,495
Closed -$306K – 2469
2023
Q2 		$306K Buy
+28,495
New +$303K ﹤0.01% 1614
2022
Q2 		– Sell
-14,180
Closed -$148K – 3019
2022
Q1 		$148K Buy
+14,180
New +$192K ﹤0.01% 2562

Other funds holding CGEM

LCM
Lynx1 Capital Management San Juan, Puerto Rico $633M AUM 173.22% 1-Year Est. Return
MB
MPM BioImpact Boston, Massachusetts $1.29B AUM 141.72% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
KCM
Kynam Capital Management Princeton, New Jersey $1.58B AUM 138.67% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
BOCH
Blue Owl Capital Holdings New York $369M AUM 78.25% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return